Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$47.31

0.43 (0.92%)

06:07
08/14/18
08/14
06:07
08/14/18
06:07

Novo Nordisk management to meet with Morgan Stanley

Meeting to be held in New York on August 14 hosted by Morgan Stanley.

  • 14

    Aug

  • 25

    Aug

NVO Novo Nordisk
$47.31

0.43 (0.92%)

04/05/18
RHCO
04/05/18
NO CHANGE
Target $101
RHCO
Buy
Eli Lilly supported by positive oncology and diabetes findings, says SunTrust
SunTrust analyst John Boris keeps his Buy rating and $101 price target on Eli Lilly (LLY), citing the latest developments in Oncology and Diabetes. In Oncology, Boris points to the positive Overall Survival and Progression Free Survival data for Cyramza in second-line hepatocellular carcinoma, though he sees the commercial opportunity in Hepatocellular Carcinoma as limited. In Diabetes, the analyst points to the latest data showing Trulicity gaining market share on Novo Nordisk's (NVO) Victoza in the GLP-1 market.
06/01/18
ROTH
06/01/18
NO CHANGE
Target $400
ROTH
Buy
Roth Capital ups Madrigal price target to $400, examines possible M&A scenarios
Roth Capital analyst Yasmeen Rahimi noted that Madrigal Pharmaceuticals' (MDGL) "impressive" NASH resolution results published yesterday resulted in the stock's value being pushed up to make it the highest among "purely NASH" companies. Among large pharma companies, Rahimi believes those with the strongest metabolic franchises, large R&D teams, and sales forces focused on endocrinologists, gastroenterologists, and hepatologists likely have eyes on NASH assets, listing Merck (MRK), AstraZeneca (AZN), Eli Lilly (LLY) and Novo Nordisk (NVO) as examples. The historical acquisition price for NASH assets ranges from $200M to $1.7B, but Rahimi argues that Madrigal "can set the highest NASH price tag yet," estimating a potential takeout valuation of $5.6B. Rahimi raised her price target on Madrigal shares to $400 from $210 and keeps a Buy rating on the stock.
07/02/18
BERN
07/02/18
UPGRADE
BERN
Outperform
Novo Nordisk upgraded to Outperform from Market Perform at Bernstein
07/19/18
BMOC
07/19/18
NO CHANGE
Target $80
BMOC
Market Perform
Eli Lilly to have a 'good Q2' on beats from launch franchises, says BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Eli Lilly to $80 from $78 ahead of its Q2 earnings, saying the company will have a "good" quarter on "beats from its launch franchises Trulicity, Jardiance, and Basaglar". The analyst also keeps his Market Perform rating, adding that while the the pipeline potential of its Galcanezumab and Tanezumab drugs is promising, he believes investors are underappreciating the headwinds around its diabetes program. He see higher risks of an increased biosimilar erosion for Humalog from Sanofi's (SNY) Admelog, and Trulicity competitive pressure from Novo's (NVO) Ozempic in 2019.

TODAY'S FREE FLY STORIES

AGCO

Agco

$69.70

-1.9 (-2.65%)

15:50
04/25/19
04/25
15:50
04/25/19
15:50
Hot Stocks
Agco raises quarterly dividend to 16c per share from 15c »

Agco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 05

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

BHC

Bausch Health

$23.82

0.8 (3.48%)

15:45
04/25/19
04/25
15:45
04/25/19
15:45
Recommendations
Bausch Health analyst commentary at Wells Fargo »

Bausch Health pipeline,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 06

    May

  • 06

    May

NBLX

Noble Midstream

$38.92

1.49 (3.98%)

, NBL

Noble Energy

$27.51

-0.08 (-0.29%)

15:44
04/25/19
04/25
15:44
04/25/19
15:44
Periodicals
Noble Midstream put up for sale by Noble Energy, Reuters says »

Noble Midstream Partners…

NBLX

Noble Midstream

$38.92

1.49 (3.98%)

NBL

Noble Energy

$27.51

-0.08 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

INTC

Intel

$57.52

-1.2 (-2.04%)

15:40
04/25/19
04/25
15:40
04/25/19
15:40
Options
Intel options volume is 2X daily average ahead of earnings »

Intel options volume is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 16

    May

  • 03

    Jun

S

Sprint

$5.54

-0.08 (-1.42%)

, TMUS

T-Mobile

$73.06

-0.29 (-0.40%)

15:38
04/25/19
04/25
15:38
04/25/19
15:38
Periodicals
Sprint, T-Mobile officials 'cautiously optimistic' about DOJ approval, FBN says »

The U.S. Department of…

S

Sprint

$5.54

-0.08 (-1.42%)

TMUS

T-Mobile

$73.06

-0.29 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

SFLY

Shutterfly

$42.23

-0.72 (-1.68%)

15:34
04/25/19
04/25
15:34
04/25/19
15:34
Options
Shutterfly options imply 13.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

XLU

Utilities SPDR

$58.16

0.38 (0.66%)

15:30
04/25/19
04/25
15:30
04/25/19
15:30
Options
Put spreads in SPDR Utility Fund as a defensive position is adjusted »

Put spreads in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$20.19

-0.565 (-2.72%)

15:29
04/25/19
04/25
15:29
04/25/19
15:29
Hot Stocks
EQT Corporation responds to Toby Rice lawsuit »

EQT Corporation issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

NBLX

Noble Midstream

$36.79

-0.64 (-1.71%)

, NBL

Noble Energy

$26.70

-0.89 (-3.23%)

15:22
04/25/19
04/25
15:22
04/25/19
15:22
Periodicals
Breaking Periodicals news story on Noble Midstream, Noble Energy »

Noble Midstream put up…

NBLX

Noble Midstream

$36.79

-0.64 (-1.71%)

NBL

Noble Energy

$26.70

-0.89 (-3.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 03

    May

GM

General Motors

$39.16

-0.57 (-1.43%)

15:20
04/25/19
04/25
15:20
04/25/19
15:20
Hot Stocks
GM adds second shift, over 400 hourly jobs to Kentucky assembly plant »

General Motors said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 05

    Jun

ALKS

Alkermes

$31.49

-3.31 (-9.51%)

15:20
04/25/19
04/25
15:20
04/25/19
15:20
Recommendations
Alkermes analyst commentary at Piper Jaffray »

Piper points to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ZNGA

Zynga

$5.46

-0.125 (-2.24%)

15:20
04/25/19
04/25
15:20
04/25/19
15:20
Options
Size call spread in Zynga adjusts a bullish position »

Size call spread in Zynga…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 07

    May

  • 13

    Nov

JNPR

Juniper

$28.11

-0.615 (-2.14%)

15:19
04/25/19
04/25
15:19
04/25/19
15:19
Options
Juniper options imply 10.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
04/25/19
04/25
15:17
04/25/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
04/25/19
04/25
15:16
04/25/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADM

Archer Daniels

$42.08

-0.68 (-1.59%)

15:15
04/25/19
04/25
15:15
04/25/19
15:15
Options
Archer Daniels put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 13

    Nov

CLS

Celestica

$7.33

-1.275 (-14.82%)

15:06
04/25/19
04/25
15:06
04/25/19
15:06
Downgrade
Celestica rating change at CIBC »

Celestica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

MAT

Mattel

$12.39

-0.16 (-1.27%)

15:04
04/25/19
04/25
15:04
04/25/19
15:04
Options
Mattel options imply 17.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 16

    May

  • 12

    Jun

MDP

Meredith

$58.14

-0.21 (-0.36%)

15:02
04/25/19
04/25
15:02
04/25/19
15:02
Periodicals
Authentic Brands in talks to buy Sports Illustrated from Meredith, WSJ says »

Authentic Brands has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 09

    May

  • 13

    Nov

CMG

Chipotle

$676.86

-33.14 (-4.67%)

14:59
04/25/19
04/25
14:59
04/25/19
14:59
Recommendations
Chipotle analyst commentary at Argus »

Chipotle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 29

    May

MS

Morgan Stanley

$47.53

0.14 (0.30%)

14:58
04/25/19
04/25
14:58
04/25/19
14:58
Hot Stocks
California AG announces $150M settlement agreement with Morgan Stanley »

California Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 11

    Jun

SBUX

Starbucks

$76.81

0.39 (0.51%)

14:53
04/25/19
04/25
14:53
04/25/19
14:53
Earnings
Fly Intel: What to watch in Starbucks earnings report »

Starbucks (SBUX) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AKAM

Akamai

$78.74

0.61 (0.78%)

14:53
04/25/19
04/25
14:53
04/25/19
14:53
Conference/Events
Akamai management to meet with William Blair »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 02

    May

  • 15

    May

  • 06

    Jun

AMZN

Amazon.com

$1,915.66

14.94 (0.79%)

14:50
04/25/19
04/25
14:50
04/25/19
14:50
On The Fly
Fly Intel: What to watch in Amazon earnings report »

Amazon (AMZN) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

AMP

Ameriprise

$145.43

1.475 (1.02%)

14:50
04/25/19
04/25
14:50
04/25/19
14:50
Recommendations
Ameriprise analyst commentary at Citi »

Ameriprise price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.